Search

everythinglearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Young patients are more likely to develop autoimmune diseases, while elderly patients are more prone to organ failure after DRESS.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

The DHT immunoassay is unreliable due to high cross-reactivity with testosterone.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Etanercept effectively treated a severe skin condition when other treatments failed.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

Cyproterone acetate effectively treats hirsutism and related conditions.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

Baricitinib is a promising treatment for alopecia areata.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Autoimmune Polyendocrine Syndromes involve specific combinations of autoimmune diseases.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Some people with chronic hair loss may have thyroid autoimmunity.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

RC48 shows promise for treating certain advanced cancers, but more research is needed.